Deal Mechanic: CBPE & Rosemont Pharmaceuticals

In its six years as owner of Rosemont Pharmaceuticals, CBPE helped the business to overhaul its manufacturing process, expand its product line and bolster its management team – more than doubling EBITDA in the process.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this